• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测和验证 Ov58GPCR 的结构特征,Ov58GPCR 是盘尾丝虫的一个免疫原决定簇。

Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus.

机构信息

Department of Molecular Biology, Institute of Biology and Molecular Medicine, IBMM Universite Libre de Bruxelles, Gosselies Campus, Gosselies, Hainaut, Belgium.

Molecular and Cell Biology Laboratory, Biotechnology Unit, Faculty of Science, University of Buea, Buea, Cameroon.

出版信息

PLoS One. 2018 Sep 26;13(9):e0202915. doi: 10.1371/journal.pone.0202915. eCollection 2018.

DOI:10.1371/journal.pone.0202915
PMID:30256790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6157839/
Abstract

Onchocerciasis is a severely debilitating yet neglected tropical disease (NTD) that creates social stigma, generates and perpetuates poverty, and leads ultimately in some cases to irreversible unilateral or bilateral blindness if untreated. Consequently, the disease is a major impediment to socioeconomic development. Many control programs have been launched for the disease with moderate successes achieved. This mitigated hit is partially due to the lingering need for reliable, non-invasive and easily applicable tools for mapping endemic regions and post-elimination surveillance. In this work, bioinformatics analyses combined with immunological assays were applied in a bid to develop potential tools for diagnosis and assessing the success of drug treatment programs. We report that (i) the O. volvulus antigen, Ov58GPCR is a G-protein coupled receptor (GPCR) conserved in related nematodes, (ii) synthetic peptides predicted to be in the extracellular domain (ECD) of Ov58GPCR are indeed immunogenic epitopes in actively-infected individuals, (iii) synthetic peptide cocktails discriminate between actively-infected individuals, treated individuals and healthy African controls, (iv) polyclonal antibodies against one of the peptides or against the bacterially-expressed ECD reacted specifically with the native antigen of O. volvulus total and surface extracts, (v) Ov58GPCR is transcribed in both larvae and adult parasite stages, (vi) IgG and IgE responses to the recombinant ECD decline with ivermectin treatment. All these findings suggest that the extracellular domain and synthetic peptides of Ov58GPCR, as well as the specific immune response generated could be harnessed in the context of disease diagnosis and surveillance.

摘要

盘尾丝虫病是一种严重的使人丧失能力但被忽视的热带病(NTD),它会造成社会耻辱,引发和加剧贫困,并最终在某些情况下导致不可逆转的单侧或双侧失明,如果不治疗的话。因此,这种疾病是社会经济发展的主要障碍。已经为这种疾病发起了许多控制项目,并取得了一定的成功。这种部分缓解的情况部分归因于仍然需要可靠、非侵入性和易于应用的工具来绘制流行地区地图和进行消除后监测。在这项工作中,生物信息学分析与免疫学检测相结合,旨在开发潜在的诊断工具和评估药物治疗方案的成功。我们报告称:(i)盘尾丝虫抗原 Ov58GPCR 是一种在相关线虫中保守的 G 蛋白偶联受体(GPCR),(ii)预测位于 Ov58GPCR 细胞外结构域(ECD)的合成肽实际上是在活动性感染个体中具有免疫原性的表位,(iii)合成肽混合物能够区分活动性感染个体、治疗个体和健康的非洲对照个体,(iv)针对其中一种肽或针对细菌表达的 ECD 的多克隆抗体与 O. volvulus 总蛋白和表面提取物的天然抗原特异性反应,(v)Ov58GPCR 在幼虫和成虫寄生虫阶段都有转录,(vi)针对重组 ECD 的 IgG 和 IgE 反应随着伊维菌素治疗而下降。所有这些发现表明,Ov58GPCR 的细胞外结构域和合成肽以及产生的特异性免疫反应可以在疾病诊断和监测的背景下得到利用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/3d96e762d9be/pone.0202915.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/23d3115e5d2a/pone.0202915.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/588f36d54fd2/pone.0202915.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/10c9f9d59133/pone.0202915.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/5959c2fb4852/pone.0202915.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/97e19e731a37/pone.0202915.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/9dc40c1d0124/pone.0202915.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/3d96e762d9be/pone.0202915.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/23d3115e5d2a/pone.0202915.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/588f36d54fd2/pone.0202915.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/10c9f9d59133/pone.0202915.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/5959c2fb4852/pone.0202915.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/97e19e731a37/pone.0202915.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/9dc40c1d0124/pone.0202915.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5f8/6157839/3d96e762d9be/pone.0202915.g007.jpg

相似文献

1
Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus.预测和验证 Ov58GPCR 的结构特征,Ov58GPCR 是盘尾丝虫的一个免疫原决定簇。
PLoS One. 2018 Sep 26;13(9):e0202915. doi: 10.1371/journal.pone.0202915. eCollection 2018.
2
The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.盘尾丝虫感染不同阶段人类免疫的多样表达。
Immunology. 1997 Apr;90(4):592-9. doi: 10.1046/j.1365-2567.1997.00210.x.
3
Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.反复接受伊维菌素治疗16年后盘尾丝虫病患者体内抗盘尾丝虫特异性抗体和细胞因子反应
Clin Exp Immunol. 2007 Mar;147(3):504-12. doi: 10.1111/j.1365-2249.2006.03312.x.
4
The effect of ivermectin treatment on the antibody response to antigens of Onchocerca volvulus.伊维菌素治疗对盘尾丝虫抗原抗体反应的影响。
Trans R Soc Trop Med Hyg. 1994 Jul-Aug;88(4):456-60. doi: 10.1016/0035-9203(94)90433-2.
5
Recent updates on onchocerciasis: diagnosis and treatment.盘尾丝虫病的最新进展:诊断与治疗
Clin Infect Dis. 2007 Jan 1;44(1):53-60. doi: 10.1086/509325. Epub 2006 Nov 29.
6
Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.在实施多年疾病控制项目后对比奥科岛(赤道几内亚)盘尾丝虫病血清流行率的评估。
Parasit Vectors. 2016 Sep 20;9(1):509. doi: 10.1186/s13071-016-1779-8.
7
Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings.被忽视热带病诊断建模:在接近消除和监测环境中,皮肤活检对盘尾丝虫病的敏感性
Parasit Vectors. 2016 Jun 14;9(1):343. doi: 10.1186/s13071-016-1605-3.
8
Immunoglobulin G subclass responses of children during infection with Onchocerca volvulus.盘尾丝虫感染期间儿童的免疫球蛋白G亚类反应。
Clin Diagn Lab Immunol. 1996 Jan;3(1):98-104. doi: 10.1128/cdli.3.1.98-104.1996.
9
Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.伊维菌素促进盘尾丝虫病的免疫;亚临床盘尾丝虫感染激活寄生虫特异性Th1型反应。
Clin Exp Immunol. 1994 May;96(2):238-44. doi: 10.1111/j.1365-2249.1994.tb06548.x.
10
A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.在埃塞俄比亚西南部吉马地区未绘制地图的村庄开展的一项基于社区的横断面研究,旨在了解盘尾丝虫病的流行病学情况,以便进行伊维菌素的社区导向治疗。
BMC Public Health. 2015 Jul 1;15:595. doi: 10.1186/s12889-015-1888-x.

引用本文的文献

1
Beyond Tradition: Exploring Cutting-Edge Approaches for Accurate Diagnosis of Human Filariasis.超越传统:探索人类丝虫病准确诊断的前沿方法。
Pathogens. 2024 May 24;13(6):447. doi: 10.3390/pathogens13060447.
2
Computational Design and Preliminary Serological Analysis of a Novel Multi-Epitope Vaccine Candidate against Onchocerciasis and Related Filarial Diseases.一种针对盘尾丝虫病及相关丝虫病的新型多表位候选疫苗的计算设计与初步血清学分析
Pathogens. 2021 Jan 21;10(2):99. doi: 10.3390/pathogens10020099.
3
The Functional Parasitic Worm Secretome: Mapping the Place of Excretory Secretory Products.

本文引用的文献

1
Identification and characterization of the Onchocerca volvulus Excretory Secretory Product Ov28CRP, a putative GM2 activator protein.鉴定和描述旋毛形线虫排泄分泌产物 Ov28CRP,一种潜在的 GM2 激活蛋白。
PLoS Negl Trop Dis. 2019 Jul 22;13(7):e0007591. doi: 10.1371/journal.pntd.0007591. eCollection 2019 Jul.
2
MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms.MEGA X:跨越计算平台的分子进化遗传学分析。
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549. doi: 10.1093/molbev/msy096.
3
Diagnostics for onchocerciasis in the era of elimination.
功能性寄生蠕虫分泌蛋白质组:绘制排泄分泌产物的定位图
Pathogens. 2020 Nov 23;9(11):975. doi: 10.3390/pathogens9110975.
4
In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis.用于人类盘尾丝虫病诊断的嵌合抗原OvMANE1的计算机辅助设计与验证
Pathogens. 2020 Jun 22;9(6):495. doi: 10.3390/pathogens9060495.
5
Identification and characterization of the Onchocerca volvulus Excretory Secretory Product Ov28CRP, a putative GM2 activator protein.鉴定和描述旋毛形线虫排泄分泌产物 Ov28CRP,一种潜在的 GM2 激活蛋白。
PLoS Negl Trop Dis. 2019 Jul 22;13(7):e0007591. doi: 10.1371/journal.pntd.0007591. eCollection 2019 Jul.
消除盘尾丝虫病时代的盘尾丝虫病诊断方法
Int Health. 2018 Mar 1;10(suppl_1):i20-i26. doi: 10.1093/inthealth/ihx047.
4
A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.罗阿丝虫病流行地区盘尾丝虫病的检测而非治疗策略。
N Engl J Med. 2017 Nov 23;377(21):2044-2052. doi: 10.1056/NEJMoa1705026. Epub 2017 Nov 8.
5
O-5S quantitative real-time PCR: a new diagnostic tool for laboratory confirmation of human onchocerciasis.O-5S 定量实时 PCR:一种用于实验室确诊人体盘尾丝虫病的新诊断工具。
Parasit Vectors. 2017 Oct 2;10(1):451. doi: 10.1186/s13071-017-2382-3.
6
Onchocerca volvulus: The Road from Basic Biology to a Vaccine.旋毛形线虫:从基础生物学到疫苗的道路。
Trends Parasitol. 2018 Jan;34(1):64-79. doi: 10.1016/j.pt.2017.08.011. Epub 2017 Sep 22.
7
Important progress towards elimination of onchocerciasis in the West Region of Cameroon.喀麦隆西部地区在消除盘尾丝虫病方面取得重要进展。
Parasit Vectors. 2017 Aug 3;10(1):373. doi: 10.1186/s13071-017-2301-7.
8
BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes.BepiPred-2.0:利用构象表位改进基于序列的 B 细胞表位预测。
Nucleic Acids Res. 2017 Jul 3;45(W1):W24-W29. doi: 10.1093/nar/gkx346.
9
Identification of three immunodominant motifs with atypical isotype profile scattered over the Onchocerca volvulus proteome.在盘尾丝虫蛋白质组中鉴定出三个具有非典型同种型谱且分布分散的免疫显性基序。
PLoS Negl Trop Dis. 2017 Jan 26;11(1):e0005330. doi: 10.1371/journal.pntd.0005330. eCollection 2017 Jan.
10
Factors affecting onchocerciasis transmission: lessons for infection control.影响盘尾丝虫病传播的因素:感染控制的经验教训。
Expert Rev Anti Infect Ther. 2017 Apr;15(4):377-386. doi: 10.1080/14787210.2017.1286980. Epub 2017 Feb 3.